Zacks Research Upgrades Nutex Health (NASDAQ:NUTX) to “Hold”

by · The Markets Daily

Nutex Health (NASDAQ:NUTX – Get Free Report) was upgraded by stock analysts at Zacks Research to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports.

NUTX has been the subject of a number of other reports. Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Lake Street Capital began coverage on shares of Nutex Health in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target on the stock. Finally, B. Riley Financial assumed coverage on shares of Nutex Health in a research note on Friday, June 26th. They set a “buy” rating and a $290.00 price objective on the stock. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Nutex Health has a consensus rating of “Moderate Buy” and a consensus price target of $243.33.

Read Our Latest Stock Report on NUTX

Nutex Health Trading Up 2.0%

Shares of NASDAQ NUTX opened at $170.89 on Monday. Nutex Health has a fifty-two week low of $77.21 and a fifty-two week high of $193.07. The firm has a market capitalization of $1.18 billion, a P/E ratio of 13.21 and a beta of 0.26. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The company’s 50 day simple moving average is $131.86 and its 200 day simple moving average is $129.94.

Nutex Health (NASDAQ:NUTX – Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. The firm had revenue of $216.49 million during the quarter, compared to analyst estimates of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. On average, analysts predict that Nutex Health will post 22.72 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. Islay Capital Management LLC acquired a new stake in shares of Nutex Health in the fourth quarter valued at about $34,000. BNP Paribas Financial Markets lifted its holdings in Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares during the last quarter. Royal Bank of Canada boosted its position in Nutex Health by 752.4% during the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after purchasing an additional 316 shares during the period. Bank of America Corp DE increased its holdings in shares of Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after purchasing an additional 2,043 shares during the last quarter. Finally, EverSource Wealth Advisors LLC bought a new position in shares of Nutex Health in the first quarter valued at about $83,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

(Get Free Report)

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

See Also